Literature DB >> 1371985

Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping.

C A Hanson1, C W Ross, B Schnitzer.   

Abstract

Anti-CD34 is a monoclonal antibody that reacts with bone marrow progenitor cells and leukemic blasts, and is expressed on 30% to 50% of all acute leukemias. Detection of CD34 has previously been restricted to flow cytometric studies. To expand the utility of CD34, we immunostained 46 paraffin-embedded bone marrow specimens with acute leukemia; results were compared with flow cytometric studies. CD34 reactivity was also evaluated in nine chronic leukemia cases, 27 malignant lymphoma cases (Hodgkin's disease and non-Hodgkin's lymphoma), six normal bone marrow specimens, and three benign, hyperplastic lymph node specimens. All cases that were CD34 positive by flow cytometry (11 of 19 B-cell precursor acute lymphoblastic leukemia cases, one of six T-cell acute lymphoblastic leukemia cases, and seven of 21 acute myeloblastic leukemia cases) were also CD34 positive in paraffin sections. Both cell membrane and cytoplasmic staining was seen. The positivity percentage and fluorescence intensity by flow cytometry correlated with the estimated number of stained cells and the intensity of immunoperoxidase staining in 18 of 19 CD34-positive cases. The remaining bone marrow and lymph node cases studied were CD34 negative; prominent endothelial cell staining, however, was noted. This is the first report of anti-CD34 staining of acute leukemia in paraffin-embedded sections. In contrast to other monoclonal antibodies reactive in bone marrow paraffin sections with leukemia, anti-CD34 immunoperoxidase staining is limited to leukemic blasts and may provide useful diagnostic information when flow cytometric studies are not available.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371985     DOI: 10.1016/0046-8177(92)90006-o

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  Immunoblot analysis of CD34 expression in histologically diverse neoplasms.

Authors:  Y Natkunam; R V Rouse; S Zhu; C Fisher; M van De Rijn
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  Establishment and characterization of a novel CD34-positive human myeloid leukemia cell line: MHH225 growing in serum-free culture.

Authors:  H T Hassan; E Petershofen; E Lux; C Fonatsch; G Heil; M Freund
Journal:  Ann Hematol       Date:  1995-09       Impact factor: 3.673

3.  QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens.

Authors:  H P Horny; M Wehrmann; H U Schlicker; A Eichstaedt; M R Clemens; E Kaiserling
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

4.  Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas.

Authors:  C H Graham; J Rivers; R S Kerbel; K S Stankiewicz; W L White
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.